Intensity Modulated Radiation Therapy (IMRT) Radiotherapy for Treating Prostate Pelvic Nodes
| Status: | Completed |
|---|---|
| Conditions: | Prostate Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/14/2017 |
| Start Date: | March 2005 |
| End Date: | March 2016 |
A Phase II Prostate Cancer Trial Treating Pelvic Lymph Nodes to High Dose Using Intensity Modulated Radiation Therapy
The purpose of this study is to examine the clinical feasibility and efficacy of uing IMRT to
escalate the biologically effective dose to the pelvic lymph nodes in a short course of
radiation therapy. An increased total and biologically effective dose will be delivered to
the pelvic lymph nodes (56 Gy at 2 Gy/fraction). The prostate will receive standard "short
course" IMRT of radiation (70 Gy at 2.5 Gy/fraction).
escalate the biologically effective dose to the pelvic lymph nodes in a short course of
radiation therapy. An increased total and biologically effective dose will be delivered to
the pelvic lymph nodes (56 Gy at 2 Gy/fraction). The prostate will receive standard "short
course" IMRT of radiation (70 Gy at 2.5 Gy/fraction).
Inclusion Criteria:
- Prostate cancer stage T-T3
- Predicted risk of lymph node involvement > 15%
- Gleason > 7
Exclusion Criteria:
- Distance metastases
- Use of anti-coagulant therapy
We found this trial at
1
site
600 Highland Ave
Madison, Wisconsin 53792
Madison, Wisconsin 53792
(608) 263-6400
University of Wisconsin Hospital and Clinics UW Health strives to meet the health needs of...
Click here to add this to my saved trials
